New Delhi: Chronic obstructive pulmonary disease (COPD), long considered a smoker's disease in old age, is increasingly being diagnosed in people decades younger, new research found. A study published ...
Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Please provide your email address to receive an email when new articles are posted on . This analysis examined three phenotypes of pulmonary hypertension (PH) associated with COPD. Patients with ...
“This new COPD diagnostic schema, which includes chest imaging, respiratory symptoms and spirometry, identified additional individuals at risk of poor respiratory outcomes,” said Bhatt, a professor in ...
LA JOLLA, Calif.--(BUSINESS WIRE)--#Biotech--AeroRx Therapeutics, Inc., a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic respiratory ...
Having recently scored approval for Nucala in chronic obstructive pulmonary disease (COPD), GSK has now signed a major $12 billion biobucks deal designed to strengthen the pharma’s offering for the ...
Roche’s hopes of getting its chronic obstructive pulmonary disease (COPD) drug astegolimab to regulators this year have taken a hit after the anti-ST2 monoclonal antibody failed to reduce flare-ups in ...
A who’s who of respiratory disease drug developers has backed the American Lung Association’s push to help chronic obstructive pulmonary disease (COPD) patients in rural communities. Sanofi and ...
Scientists have discovered that people with COPD have lung cells that contain over three times as much soot-like carbon as those of smokers without the disease. These overloaded cells are larger and ...
Sly Stone, an icon of funk music, has died at the age of 82 following a prolonged battle with COPD, a chronic lung condition that can block airflow and cause difficulty breathing. "It is with profound ...
Please provide your email address to receive an email when new articles are posted on . The FDA based mepolizumab’s approval on phase 3 MATINEE and METREX trial results. Mepolizumab has been assessed ...
SAN FRANCISCO — A new diagnostic schema incorporating chest CT and respiratory symptoms into the diagnosis of chronic obstructive pulmonary disease (COPD) can help to better identify patients at risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback